Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.24 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1658
    -0.0025 (-0.22%)
     
  • GBP/USD

    1.2554
    +0.0021 (+0.17%)
     
  • Bitcoin GBP

    50,834.41
    -242.87 (-0.48%)
     
  • CMC Crypto 200

    1,312.63
    +35.65 (+2.79%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +449.98 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.12 (-0.15%)
     
  • GOLD FUTURES

    2,310.10
    +1.50 (+0.06%)
     
  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.82 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

Biogen Stock Rises After Earnings, Jump in Sales of Alzheimer’s Drug

Biogen Stock Rises After Earnings, Jump in Sales of Alzheimer’s Drug

Biogen stock moved higher after the biopharmaceutical company reported better-than-expected earnings and a hefty increase in sales of its Alzheimer’s drug. Biogen reported first-quarter adjusted earnings of $3.67 a share from revenue of $2.29 billion. Optimistic commentary from Biogen regarding its Alzheimer’s treatment Leqembi contributed to Wednesday’s gain.